Skip to main content

07-11-2017 | ACR 2017 | Video

Biologic use during pregnancy poses no serious infection risk in infants

Lead author Christina Chambers outlines the findings of an investigation into the effects of biologic therapy in pregnant women with rheumatoid arthritis on the risk for opportunistic infections in the babies.

Please log in to get access to this content